|

Aminolevulinic Acid Intravenous Formulation SONALA-001 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: ALA Intravenous Formulation SONALA-001, SONALA 001, SONALA-001, SONALA001

Pipeline

Early 1: 1

Top Sponsors

  • Mayo Clinic1

Indications

  • Progressive Glioblastoma1
  • Recurrent Glioblastoma1
  • Cancer1

Rochester, Minnesota1 trial

Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma

Mayo Clinic in Rochester

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.